The invisible inflammation that can fuse the human spine
In short: Axial spondyloarthritis is an immune-mediated disease that targets the axial skeleton, primarily the spine and pelvis. While it often strikes in the teens and 20s, its effects are profound: an overactive immune system can cause bones to fuse together, creating a permanent, rigid structure that limits mobility.
Axial spondyloarthritis (axSpA) is an umbrella term for a family of chronic inflammatory disorders. It is distinguished from peripheral arthritis by its focus on the axial skeleton—the spine, chest, and pelvis—rather than the limbs. While it affects about 1% of the global population, it typically manifests in young adults under the age of 40. The condition is characterized by an unregulated immune system that attacks joints, muscles, and bones, leading to symptoms like persistent back pain, stiffness that worsens at night, and extreme fatigue.
The progression of the disease is complex. It often begins with enthesopathic inflammation at the enthesis, where tendons join bone. Over time, this can progress to ossifying enthesitis and eventually ankylosis, the fusion of the spine's bones. While some patients remain fully independent, others may become severely disabled as the spine locks into a fixed position. The disease is also associated with systemic complications, including cardiovascular disease, osteoporosis, and spinal fractures, as well as unrelated issues like eye inflammation or diarrhea.
Diagnosis and treatment are evolving. Ankylosing spondylitis (AS) is the radiographic form of the disease, visible on X-rays, while non-radiographic axial spondyloarthritis (nr-axSpA) may only be detectable via MRI. While there is no cure to reverse existing damage, modern therapies like anti-TNF medications and biological treatments aim to delay progression. Notably, research into methotrexate suggests it may help by increasing the apoptosis of activated T cells, potentially reducing the body's tendency to develop antibodies against these vital medications.
Opens the Intellect+ feed with this card first. Swipe up for the next one.
Sources
- Summary by Intellect · source: Ankylosing spondylitis
- Also: Axial spondyloarthritis
- Also: Axial Spondyloarthritis: Symptoms & Treatment
- Also: Frontiers in pharmacology — Biologic and targeted synthetic therapies in ankylosing spondylitis: a pharmacological review. · CC BY
To cite this card, link to https://intellectplus.co.uk/app/health-axial-spondyloarthritis.
How we source, check and correct cards: Editorial standards.
General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.
Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?
Related
More in Morbidity · More in Health · Latest · A–Z · All topics